Upgrade to SI Premium - Free Trial

BofA Securities Sees Trading Opportunity in Regeneron Pharma (REGN) Ahead of ASH Presentation

December 7, 2020 6:43 AM
BofA Securities analyst Geoff Meacham reiterated a $625.00 price target on Regeneron Pharma (NASDAQ: REGN) expecting shares to trade up ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments